Deep Learning-Enabled, Detection of Rare Circulating Tumor Cell Clusters in Whole Blood Using Label-free, Flow Cytometry
Preprint
Abstract
Metastatic tumors have poor prognoses for progression-free and overall survival for all cancer patients. Rare circulating tumor cells (CTCs) and rarer circulating tumor cell clusters (CTCCs) are potential biomarkers of metastatic growth, with CTCCs representing an increased risk factor for metastasis. Current detection platforms are optimized for ex vivo detection of CTCs only. Microfluidic chips and size exclusion methods have been proposed for CTCC detection; however, they lack in vivo utility and real-time monitoring capability. Confocal backscatter and fluorescence flow cytometry (BSFC) has been used for label-free detection of CTCCs in whole blood based on machine learning (ML) enabled peak classification. Here, we expand to a deep-learning (DL) -based, peak detection and classification model to detect CTCCs in whole blood data. We demonstrate that DL-based BSFC has a low false alarm rate of 0.78 events/min with a high Pearson correlation coefficient of 0.943 between detected events and expected events. DL-based BSFC of whole blood maintains a detection purity of 72% and a sensitivity of 35.3% for both homotypic and heterotypic CTCCs starting at a minimum size of two cells. We also demonstrate through artificial spiking studies that DL-based BSFC is sensitive to changes in the number of CTCCs present in the samples and does not add variability in detection beyond the expected variability from Poisson statistics. The performance established by DL-based BSFC motivates its use for in vivo detection of CTCCs. Further developments of label-free BSFC to enhance throughput could lead to critical applications in the clinical detection of CTCCs and ex vivo isolation of CTCC from whole blood with minimal disruption and processing steps.Keywords
All Related Versions
- Published version: Lab on a Chip, 24 (8), 2237.
This publication has 43 references indexed in Scilit:
- Synergy of photoacoustic and fluorescence flow cytometry of circulating cells with negative and positive contrastsJournal of Biophotonics, 2012
- Analysis of Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Using Epithelial Marker-Dependent and -Independent ApproachesJournal of Thoracic Oncology, 2012
- In vivo flow cytometry of circulating clots using negative photothermal and photoacoustic contrastsCytometry Part A, 2011
- Assessment of the role of circulating breast cancer cells in tumor formation and metastatic potential using in vivo flow cytometryJournal of Biomedical Optics, 2011
- Characterization of metastatic breast cancer patients with nondetectable circulating tumor cellsInternational Journal of Cancer, 2010
- Portable two-color in vivo flow cytometer for real-time detection of fluorescently-labeled circulating cellsJournal of Biomedical Optics, 2007
- Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant DiseasesClinical Cancer Research, 2004
- In Vivo Flow CytometryCancer Research, 2004
- Use of Coefficient of Variation in Assessing Variability of Quantitative AssaysClinical and Vaccine Immunology, 2002
- Analysis of a complex of statistical variables into principal components.Journal of Educational Psychology, 1933